Literature DB >> 1332911

RNase H-mediated inhibition of translation by antisense oligodeoxyribonucleotides: use of backbone modification to improve specificity.

B Larrouy1, C Blonski, C Boiziau, M Stuer, S Moreau, D Shire, J J Toulmé.   

Abstract

A sequence of the rabbit alpha-globin mRNA is the primary target for ODN1, an unmodified 15-nucleotide (nt) antisense oligodeoxyribonucleotide (oligo). ODN1 prevented in vitro translation of both alpha- and beta-globin mRNAs in wheat germ extract. Nine secondary sites exhibiting more than 60% complementarity with ODN1 were present in the beta-globin message. The ODN1 inhibition of beta-globin synthesis was shown to be mediated by RNase H cleavage of the beta-globin mRNA at three partially complementary sites. Sandwich-type oligos consisting of a stretch of unmodified nt with a few methylphosphonate residues at both 5' and 3' ends were derived from ODN1. We have demonstrated that one such analogue (ODN2), with five phosphodiester linkages in the central region, exhibited improved specificity for alpha-globin mRNA compared with the unmodified parent 15-mer, due to a reduced ability of RNase H to cleave beta-mRNA/ODN2 mismatched duplexes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332911     DOI: 10.1016/0378-1119(92)90121-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  15 in total

1.  Eukaryotic ribonucleases HI and HII generate characteristic hydrolytic patterns on DNA-RNA hybrids: further evidence that mitochondrial RNase H is an RNase HII.

Authors:  F Pileur; J J Toulme; C Cazenave
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

2.  Selective inhibition of cell-free translation by oligonucleotides targeted to a mRNA hairpin structure.

Authors:  R Le Tinévez; R K Mishra; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

3.  Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cells.

Authors:  R V Giles; C J Ruddell; D G Spiller; J A Green; D M Tidd
Journal:  Nucleic Acids Res       Date:  1995-03-25       Impact factor: 16.971

4.  Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase.

Authors:  T Laitala; H K Väänänen
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

5.  Selective inhibitory DNA aptamers of the human RNase H1.

Authors:  Frédéric Pileur; Marie-Line Andreola; Eric Dausse; Justine Michel; Serge Moreau; Hirofumi Yamada; Sergei A Gaidamakov; Robert J Crouch; Jean-Jacques Toulmé; Christian Cazenave
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

Review 6.  In vivo imaging with oligonucleotides for diagnosis and drug development.

Authors:  B Tavitian
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

7.  Real time detection of DNA.RNA hybridization in living cells.

Authors:  D L Sokol; X Zhang; P Lu; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

8.  Synthesis of oligodeoxynucleoside methylphosphonates utilizing the tert-butylphenoxyacetyl group for exocyclic amine protection.

Authors:  N D Sinha; D P Michaud; S K Roy; R A Casale
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

9.  Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells.

Authors:  I Duroux; G Godard; M Boidot-Forget; G Schwab; C Hélène; T Saison-Behmoaras
Journal:  Nucleic Acids Res       Date:  1995-09-11       Impact factor: 16.971

10.  RNase H is responsible for the non-specific inhibition of in vitro translation by 2'-O-alkyl chimeric oligonucleotides: high affinity or selectivity, a dilemma to design antisense oligomers.

Authors:  B Larrouy; C Boiziau; B Sproat; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1995-09-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.